The goal of this month's activity is to review the stepwise approach to the management of pediatric and adult asthma, and the pharmacotherapies commonly used in asthma treatment. More
Although the biosimilar Zarxio was approved in March, the manufacturer, Sandoz/Novartis, has been delayed from selling the drug until a patent dispute is resolved. More
